Gene Therapy

FIGURE 3

FROM:

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization

P Gehlbach, A M Demetriades, S Yamamoto, T Deering, E J Duh, H S Yang, C Cingolani, H Lai, L Wei and P A Campochiaro

BACK TO ARTICLE

Figure 3.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Recombinant PEDF protein diffuses into the eye from the periocular space. Adult C57BL/6 mice were given a periocular injection of 5 mul containing 3 mug of recombinant PEDF in one eye and euthanized 2, 6, or 24 h after injection. Ocular frozen sections were immunohistochemically stained for PEDF. Red reaction product demonstrates high levels of PEDF in the orbit and sclera 2 (a), 6 (b), or 24 h (c) after injection. There is little staining for PEDF in the retina 2 or 6 h after injection, but there is unequivocal staining in the retina 24 h after injection (c). Incubation of primary antibody with PEDF eliminated all but faint background staining in the episclera (d). Staining for PEDF in control, uninjected eyes showed only faint background (e). A section from a Balb/C mouse given a periocular injection of 5 times 109 particles of AdPEDF.11 showed red reaction product in the orbit and sclera and faint staining in the retina.

BACK TO ARTICLE